269 related articles for article (PubMed ID: 27955628)
1. Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
BMC Gastroenterol; 2016 Dec; 16(1):141. PubMed ID: 27955628
[TBL] [Abstract][Full Text] [Related]
2. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Muraishi N; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Suzuki Y; Ikeda K; Kumada H
Oncology; 2022; 100(1):31-38. PubMed ID: 34788749
[TBL] [Abstract][Full Text] [Related]
5. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
[TBL] [Abstract][Full Text] [Related]
7. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
8. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
Erhartova D; Cahova M; Dankova H; Heczkova M; Mikova I; Sticova E; Spicak J; Seda O; Trunecka P
PLoS One; 2019; 14(11):e0224820. PubMed ID: 31703079
[TBL] [Abstract][Full Text] [Related]
10. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
[TBL] [Abstract][Full Text] [Related]
11. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity.
Li YJ; Baumert BO; Stratakis N; Goodrich JA; Wu HT; He JX; Zhao YQ; Aung MT; Wang HX; Eckel SP; Walker DI; Valvi D; La Merrill MA; Ryder JR; Inge TH; Jenkins T; Sisley S; Kohli R; Xanthakos SA; Baccarelli AA; McConnell R; Conti DV; Chatzi L
World J Gastroenterol; 2024 Jan; 30(4):332-345. PubMed ID: 38313232
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290
[TBL] [Abstract][Full Text] [Related]
14. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.
Cengiz M; Ozenirler S
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023
[TBL] [Abstract][Full Text] [Related]
15. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.
Corey KE; Misdraji J; Gelrud L; King LY; Zheng H; Malhotra A; Chung RT
Dig Dis Sci; 2015 Aug; 60(8):2523-8. PubMed ID: 25840922
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease.
Miyaaki H; Ichikawa T; Kamo Y; Taura N; Honda T; Shibata H; Milazzo M; Fornari F; Gramantieri L; Bolondi L; Nakao K
Liver Int; 2014 Aug; 34(7):e302-7. PubMed ID: 24313922
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
18. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
